Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, 261 Mountain View Dr., Colchester, VT 05446, USA.
Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
J Proteomics. 2020 May 30;220:103753. doi: 10.1016/j.jprot.2020.103753. Epub 2020 Mar 18.
Microglia, the resident immune cells of the brain, can exhibit a broad range of activation phenotypes, many of which have been implicated in several diseases and disorders of the central nervous system including those related to alcohol abuse. Given the complexity of global-scale molecular changes that define microglial activation, accurate phenotypic classification in the context of alcohol exposure is still lacking. We employed an optimized method for deep, quantitative proteome profiling of primary microglia in order to characterize their response to acute exposure to alcohol (ethanol) as well as the pro-inflammatory driver and TLR4 agonist, LPS. From this analysis, 5,062 total proteins were identified where 4,857 and 4,928 of those proteins were quantifiable by label-free quantitation in ethanol and LPS treatment groups, respectively. This study highlights the subtle, yet significant proteomic changes that occur in ethanol-treated microglia, which do not align with the robust pro-inflammatory phenotype induced by TLR4 activation. Specifically, our results indicate inhibition of several upstream regulators associated with inflammation, opposing effects on pathways such as phagocytosis upon comparison to TLR4-mediated pro-inflammatory phenotype, and a potential metabolic shift associated with increased expression of proteins related to OXPHOS and lipid homeostasis. Data are available via ProteomeXchange with identifier PXD14466. SIGNIFICANCE: Alcohol abuse has a significant impact on the central nervous system, which includes the pathophysiological mechanisms resulting from glial cell activation. Microglia, in particular, are the resident immune cells of the brain and exhibit a broad range of activation phenotypes. The molecular changes that drive microglial activation phenotype are complex and have yet to be fully characterized in the context of alcohol exposure. Our study highlights the first and most comprehensive characterization of alcohol-induced proteomic changes in primary microglia to date and has shed light on novel immune-related and metabolic pathways that are altered due to alcohol exposure. The results from this study provide an important foundation for future work aimed to understand the complexity of alcohol-induced microglial activation in vivo and other translational models of acute and chronic alcohol exposure.
小胶质细胞是大脑的常驻免疫细胞,可表现出广泛的激活表型,其中许多与中枢神经系统的几种疾病和紊乱有关,包括与酒精滥用有关的疾病。鉴于定义小胶质细胞激活的全基因组范围分子变化的复杂性,在酒精暴露的背景下,准确的表型分类仍然缺乏。我们采用了一种优化的方法对原代小胶质细胞进行深度、定量蛋白质组学分析,以描述它们对急性酒精(乙醇)暴露以及促炎驱动因子和 TLR4 激动剂 LPS 的反应。通过该分析,鉴定了 5062 种总蛋白,其中 4857 种和 4928 种蛋白质分别可通过乙醇和 LPS 处理组的无标记定量来定量。这项研究强调了在乙醇处理的小胶质细胞中发生的微妙但显著的蛋白质组学变化,这些变化与 TLR4 激活引起的强烈促炎表型不一致。具体而言,我们的结果表明,与 TLR4 介导的促炎表型相比,几种与炎症相关的上游调节剂的活性受到抑制,吞噬作用等途径的作用相反,并且与 OXPHOS 和脂质稳态相关的蛋白质表达增加相关的潜在代谢转变。数据可通过 ProteomeXchange 以标识符 PXD14466 获得。意义:酒精滥用对中枢神经系统有重大影响,包括由神经胶质细胞激活引起的病理生理机制。小胶质细胞,特别是大脑的常驻免疫细胞,表现出广泛的激活表型。驱动小胶质细胞激活表型的分子变化很复杂,并且在酒精暴露的背景下尚未得到充分描述。我们的研究首次全面描述了迄今为止原代小胶质细胞中酒精诱导的蛋白质组学变化,并揭示了由于酒精暴露而改变的新的免疫相关和代谢途径。这项研究的结果为未来旨在理解体内酒精诱导的小胶质细胞激活的复杂性以及急性和慢性酒精暴露的其他转化模型的工作提供了重要的基础。